CRYSTAL ROGER 4

4 · Definium Therapeutics, Inc. · Filed Jun 15, 2026

AI-generated summary of this filing

Updated Jun 15, 2026

Definium (DFTX) Director Crystal Roger Receives RSU Award

What Happened

Crystal Roger, a director of Definium Therapeutics (DFTX), received equity awards on 2026-06-11 consisting of 4,666 restricted stock units (RSUs) and a 19,188-share derivative award, both reported at $0 per share. Total awarded = 23,854 shares (no cash changed hands at grant). The Form 4 was filed on 2026-06-15.

Key Details

Transaction date: 2026-06-11; reported on Form 4: 2026-06-15 (timely filing — within two business days).
Price: $0.00 per share (award/grant).
Shares owned after transaction: not specified in the data provided.
Footnotes of the filing:
- F1: The 4,666 shares are RSUs; each RSU converts to one common share and vests 1/12th monthly, with a special annual-meeting acceleration clause if applicable.
- F2: The derivative award follows a monthly 1/12 vesting schedule similar to a stock option, with the same annual-meeting acceleration clause (per the filing).
Transaction code: A (award/grant); the 19,188-item is reported as a derivative.

Context

These were equity awards (not open-market purchases or sales). RSUs and derivative awards typically vest over time and do not represent immediately tradable shares unless vested; they do not indicate an immediate buy or sell decision. No exercise or sale was reported in this filing.

Form 4

Period: 2026-06-11

Director

Transactions

Award
Common Shares
[F1]
2026-06-11+4,666→ 24,289 total
Award
Stock Option (Right to Buy)
[F2]
2026-06-11+19,188→ 19,188 total
Exercise: $24.11Exp: 2036-06-10→ Common Shares (19,188 underlying)

Footnotes (2)

[F1]These shares represent restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one common share of the Issuer. The RSUs vest as to 1/12th of the underlying shares on each monthly anniversary of the date of the grant, provided, that if the Issuer's annual meeting immediately following the date of grant takes place prior to the first anniversary of the date of grant, any unvested RSUs will vest immediately prior to the Issuer's annual meeting following the date of grant, subject the Reporting Person's continued service through the applicable vesting date.
[F2]The Stock Option vests and becomes exercisable as to 1/12th of the underlying shares on each monthly anniversary of the date of the grant, provided, that if the Issuer's annual meeting immediately following the date of grant takes place prior to the first anniversary of the date of grant, the Stock Option will vest and become exercisable immediately prior to the Issuer's annual meeting following the date of grant, subject to the Reporting Person's continued service through the applicable vesting date.

Signature

/s/ Mark Sullivan, Attorney-in-Fact for Roger Crystal|2026-06-15

2 files